Vascular endothelial growth factor G1612A (rs10434) gene polymorphism and neuropsychiatric manifestations in systemic lupus erythematosus patients

Rev Bras Reumatol Engl Ed. 2017 Mar-Apr;57(2):149-153. doi: 10.1016/j.rbre.2016.11.007. Epub 2016 Dec 14.
[Article in English, Portuguese]

Abstract

Aim: To investigate the relation between vascular endothelial growth factor (VEGF) gene polymorphism in systemic lupus erythematosus (SLE) patients and lupus related neuropsychiatric manifestations.

Patients and methods: Sixty adult SLE patients recruited from the Rheumatology and Neurology departments of Cairo University hospitals were classified into two groups; Group A: 30 patients with neuropsychiatric manifestations (NPSLE) and Group B: 30 patients without. For both groups the SNP G1612A (rs10434) of the VEGF gene was genotyped by real time polymerase chain reaction (RT-PCR).

Results: Statistically significant difference was found in genotype and allele frequencies between both groups (AA [70% vs 13.3%, p<0.001] and GG [10% vs 66.7%, p<0.001]).

Conclusion: Polymorphism in the gene coding for VEGF may be associated with increased incidence of neuropsychiatric lupus in SLE patients.

Keywords: G1612A (rs10434) gene; Gene G1612A (rs10434); LES; Manifestações neuropsiquiátricas; Neuropsychiatric manifestations; Polimorfismo; Polymorphism; SLE; VEGF.

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Female
  • Gene Expression Profiling
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Humans
  • Lupus Vasculitis, Central Nervous System / diagnosis
  • Lupus Vasculitis, Central Nervous System / genetics*
  • Lupus Vasculitis, Central Nervous System / physiopathology
  • Lupus Vasculitis, Central Nervous System / psychology*
  • Male
  • Middle Aged
  • Pilot Projects
  • Polymorphism, Single Nucleotide*
  • Vascular Endothelial Growth Factor A / genetics*
  • Vascular Endothelial Growth Factor A / metabolism
  • Young Adult

Substances

  • Vascular Endothelial Growth Factor A